JPH04500668A - プラスモジウム・ファルシパルムのメロゾイト表面抗原の対立遺伝子変異体 - Google Patents

プラスモジウム・ファルシパルムのメロゾイト表面抗原の対立遺伝子変異体

Info

Publication number
JPH04500668A
JPH04500668A JP1509913A JP50991389A JPH04500668A JP H04500668 A JPH04500668 A JP H04500668A JP 1509913 A JP1509913 A JP 1509913A JP 50991389 A JP50991389 A JP 50991389A JP H04500668 A JPH04500668 A JP H04500668A
Authority
JP
Japan
Prior art keywords
msa2
vaccine composition
antigen
falciparum
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1509913A
Other languages
English (en)
Japanese (ja)
Inventor
スミス，ジェイソン・アーサー
アンダース，ロビン・フレドリック
ケンプ，デイビッド・ジェームス
コッペル，ロス・レオン
ソウル，アラン・ジェイムス
ジョーンズ，グラハム・ロイド
アービング，デイビッド・オーエン
ダイアー，サンドラ・レイ
チィー，デイビッド・ワイ・ウィン
ゴス，ネイル・ハワード
Original Assignee
サラマン・プロプライエタリー・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サラマン・プロプライエタリー・リミテッド filed Critical サラマン・プロプライエタリー・リミテッド
Publication of JPH04500668A publication Critical patent/JPH04500668A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP1509913A 1988-09-12 1989-09-12 プラスモジウム・ファルシパルムのメロゾイト表面抗原の対立遺伝子変異体 Pending JPH04500668A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU0382 1988-09-12
AUPJ038288 1988-09-12
AUPJ596289 1989-08-24
AU5962 1991-05-02

Publications (1)

Publication Number Publication Date
JPH04500668A true JPH04500668A (ja) 1992-02-06

Family

ID=25643542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1509913A Pending JPH04500668A (ja) 1988-09-12 1989-09-12 プラスモジウム・ファルシパルムのメロゾイト表面抗原の対立遺伝子変異体

Country Status (9)

Country Link
EP (1) EP0433378B1 (da)
JP (1) JPH04500668A (da)
KR (1) KR900701831A (da)
AT (1) ATE129504T1 (da)
DE (1) DE68924649D1 (da)
DK (1) DK43991A (da)
IL (1) IL91609A0 (da)
WO (1) WO1990002752A1 (da)
ZA (1) ZA896942B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002811A1 (en) * 1988-09-16 1990-03-22 Statens Seruminstitut A malaria antigen
US20030161840A1 (en) 1992-10-19 2003-08-28 Institut Pasteur Plasmodium falciparum antigens inducing protective antibodies
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
JPS61107292A (ja) * 1984-10-30 1986-05-26 株式会社東芝 出力装置
AU595056B2 (en) * 1986-07-17 1990-03-22 Program For Appropriate Technology In Health (Path) Merozoite surface antigen of plasmodium falciparum

Also Published As

Publication number Publication date
EP0433378A1 (en) 1991-06-26
EP0433378B1 (en) 1995-10-25
ATE129504T1 (de) 1995-11-15
WO1990002752A1 (en) 1990-03-22
EP0433378A4 (en) 1991-11-06
DE68924649D1 (de) 1995-11-30
ZA896942B (en) 1990-08-29
IL91609A0 (en) 1990-04-29
DK43991D0 (da) 1991-03-12
KR900701831A (ko) 1990-12-04
DK43991A (da) 1991-05-08

Similar Documents

Publication Publication Date Title
Stanley Jr et al. Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats.
Tam et al. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T-and B-cell epitopes.
US5928901A (en) Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them
US4810492A (en) Flavivirus antigen
EP0787139A1 (en) Synthetic peptides and vaccines comprising same
US5130417A (en) Entamoeba histolytical immunogenic protein and cdna clone
JP3215692B2 (ja) 組み換えコクシジウム症ワクチン
WO1995007353A2 (en) Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
US6172192B1 (en) Toxoplasma gondii antigen Tg20
EP0153188B1 (en) Improvements in or relating to the production of malaria vaccines
US6187310B1 (en) Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kDa subunit multigene family
US5686575A (en) Toxoplasma gondii P28 polypeptides
JPH04500668A (ja) プラスモジウム・ファルシパルムのメロゾイト表面抗原の対立遺伝子変異体
CA2006587C (en) Membrane proteins and peptides of haemophilus influenzae type b
KUMAR et al. Evidence for epitope‐specific thymus‐independent response against a repeat sequence in a protein antigen
US5215917A (en) Nucleotide sequence encoding the Toxoplasma gondii P22 gene
AU638216C (en) Allelic variants of plasmodium falciparum merozoite surface antigen
EP0322394A2 (en) Expression of HIV proteins in E. coli and S. cerevisiae
WO1994020536A1 (en) Methods, compositions, and kits for diagnosing lyme disease
EP0250261A1 (en) Vaccines containing epitopes of both the CSP and a blood stage antigen of a plasmodium parasite
AU638216B2 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
US5206142A (en) Entamoeba histolytica diagnostic assay
US5916562A (en) Membrane proteins and peptides of haemophilus influenzae type B
Jones et al. Effect of context and adjuvant on the immunogenicity of recombinant proteins and peptide conjugates derived from the polymorphic malarial surface antigen MSA2
EP0297110A1 (en) Polypeptides providing protective immunity against malaria